GlassScriptPhysician profile
Jacqueline K Silverstein
NPI 1083072573
$2,669.05
in general payments reported to CMS, 2019-2025
14 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $207 · 2021: $316 · 2022: $630 · 2023: $244 · 2024: $449 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,123.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $822.82 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $523.34 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Abbvie INC. | $267.06 | 2022 | |
| Sun Pharmaceutical Industries INC. | $176.67 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $144.98 | 2020-2021 | |
| Shire North American Group INC | $136.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $134.61 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $130.53 | 2020-2025 | Acuvue |
| Harrow Eye, LLC | $108.60 | 2024 | Vevye |
| Bausch & Lomb Americas INC. | $94.02 | 2022-2025 | Infuse |
| Synergeyes, INC. | $64.63 | 2019 | |
| Oyster Point Pharma, INC. | $39.35 | 2022-2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $21.60 | 2021 | |
| Visioneering Technologies, INC. | $4.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Silverstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.